Epidermal growth factor-mediated proliferation and sodium transport in normal and PKD epithelial cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 10, 2011, Pages 1301-1313

  Zheleznova, Nadezhda N ^a   Wilson, Patricia D ^b   Staruschenko, Alexander ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

ADPKD; ARPKD; ENaC; Epidermal growth factor; ErbB receptor; ErbB2; Polycystic kidney disease

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; MAGNESIUM ION; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; POLYCYSTIN 1; POLYCYSTIN 2; RAC1 PROTEIN; SODIUM CHANNEL; SODIUM ION; TRANSIENT RECEPTOR POTENTIAL CHANNEL 5; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6;

AMINO ACID SEQUENCE; APOPTOSIS; AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE; AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE; BINDING SITE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL SURVIVAL; CYTOLOGY; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE MUTATION; HUMAN; IN VIVO STUDY; ION TRANSPORT; KIDNEY CYST; KIDNEY DEVELOPMENT; KIDNEY HYPERTROPHY; KIDNEY POLYCYSTIC DISEASE; KIDNEY TUBULE CELL; LIGAND BINDING; MESENCHYMAL STEM CELL; MOLECULAR INTERACTION; NEPHRON; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SECRETION; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; TIGHT JUNCTION;

ANIMALS; CELL PROLIFERATION; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIAL SODIUM CHANNEL; HUMANS; ION TRANSPORT; KIDNEY; MODELS, BIOLOGICAL; POLYCYSTIC KIDNEY DISEASES; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; POLYCYSTIC KIDNEY, AUTOSOMAL RECESSIVE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SODIUM; TRPP CATION CHANNELS;

RODENTIA;

EID: 80052268963     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.10.004     Document Type: Review

References (209)

1. Grantham J.J., Torres V.E., Chapman A.B., Guay-Woodford L.M., Bae K.T., King B.F., Wetzel L.H., Baumgarten D.A., Kenney P.J., Harris P.C., Klahr S., Bennett W.M., Hirschman G.N., Meyers C.M., Zhang X., Zhu F., Miller J.P. Volume progression in polycystic kidney disease. N Engl J. Med. 2006, 354:2122-2130.
2. Patel V., Chowdhury R., Igarashi P. Advances in the pathogenesis and treatment of polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 2009, 18:99-106.
3. Boletta A., Germino G.G. Role of polycystins in renal tubulogenesis. Trends Cell Biol. 2003, 13:484-492.
4. Harris P.C., Torres V.E. Polycystic kidney disease. Annu. Rev. Med. 2009, 60:321-337.
5. Torres V.E., Harris P.C. Autosomal dominant polycystic kidney disease: the last 3years. Kidney Int. 2009, 76:149-168.
6. Wilson P.D. Polycystic kidney disease. N Engl J. Med. 2004, 350:151-164.
7. Torres V.E., Harris P.C., Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007, 369:1287-1301.
8. Wilson P.D. Mouse models of polycystic kidney disease. Curr. Top. Dev. Biol. 2008, 84:311-350.
9. Kaimori J.Y., Germino G.G. ARPKD and ADPKD: first cousins or more distant relatives?. J. Am. Soc. Nephrol. 2008, 19:416-418.
10. Sullivan L.P., Wallace D.P., Grantham J.J. Epithelial transport in polycystic kidney disease. Physiol. Rev. 1998, 78:1165-1191.
11. Wilson P.D., Goilav B. Cystic disease of the kidney. Annu. Rev. Pathol. 2007, 2:341-368.
12. Melenhorst W.B., Mulder G.M., Xi Q., Hoenderop J.G., Kimura K., Eguchi S. G.H. van, Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension 2008, 52:987-993.
13. Du J., Wilson P.D. Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am. J. Physiol. 1995, 269:C487-C495.
14. Schlessinger J. Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 2002, 110:669-672.
15. Carpenter G., King L., Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 1978, 276:409-410.
16. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 2000, 103:211-225.
17. Kashles O., Szapary D., Bellot F., Ullrich A., Schlessinger J., Schmidt A. Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regions. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:9567-9571.
18. Carpenter G., Cohen S. Epidermal growth factor. J. Biol. Chem. 1990, 265:7709-7712.
19. Blaikie P., Immanuel D., Wu J., Li N., Yajnik V., Margolis B. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J. Biol. Chem. 1994, 269:32031-32034.
20. Holbro T., Hynes N.E. ErbB receptors: directing key signaling networks throughout life. Annu. Rev. Pharmacol. Toxicol. 2004, 44:195-217.
21. Zeng F., Singh A.B., Harris R.C. The role of the EGF family of ligands and receptors in renal development, physiology and pathophysiology. Exp. Cell Res. 2009, 315:602-610.
22. Zeng F., Zhang M.Z., Singh A.B., Zent R., Harris R.C. ErbB4 isoforms selectively regulate growth factor induced Madin-Darby canine kidney cell tubulogenesis. Mol. Biol. Cell 2007, 18:4446-4456.
23. Levchenko V., Zheleznova N.N., Pavlov T.S., Vandewalle A., Wilson P.D., Staruschenko A. EGF and its related growth factors mediate sodium transport in mpkCCD(c14) cells via ErbB2 (neu/HER-2) receptor. J. Cell. Physiol. 2010, 223:252-259.
24. Press M.F., Cordon-Cardo C., Slamon D.J. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Oncogene 1990, 5:953-962.
25. Pavlov T.S., Chahdi A., Ilatovskaya D.V., Levchenko V., Vandewalle A., Pochynyuk O., Sorokin A., Staruschenko A. Endothelin-1 inhibits the epithelial Na+channel through betaPix/14-3-3/Nedd4-2. J. Am. Soc. Nephrol. 2010, 21:833-843.
26. Hobert M.E., Kil S.J., Medof M.E., Carlin C.R. The cytoplasmic juxtamembrane domain of the epidermal growth factor receptor contains a novel autonomous basolateral sorting determinant. J. Biol. Chem. 1997, 272:32901-32909.
27. Hobert M.E., Friend L.A., Carlin C.R. Regulation of EGF signaling by cell polarity in MDCK kidney epithelial cells. J. Cell. Physiol. 1999, 181:330-341.
28. Harris R.C., Chung E., Coffey R.J. EGF receptor ligands. Exp. Cell Res. 2003, 284:2-13.
29. Singh A.B., Harris R.C. Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell. Signal. 2005, 17:1183-1193.
30. Witsch E., Sela M., Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda) 2010, 25:85-101.
31. Feigin M.E., Muthuswamy S.K. ErbB receptors and cell polarity: new pathways and paradigms for understanding cell migration and invasion. Exp. Cell Res. 2009, 315:707-716.
32. Tzahar E., Waterman H., Chen X., Levkowitz G., Karunagaran D., Lavi S., Ratzkin B.J., Yarden Y. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol. 1996, 16:5276-5287.
33. Graus-Porta D., Beerli R.R., Daly J.M., Hynes N.E. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J. 1997, 16:1647-1655.
34. Citri A., Skaria K.B., Yarden Y. The deaf and the dumb: the biology of ErbB-2 and ErbB-3. Exp. Cell Res. 2003, 284:54-65.
35. Berger M.B., Mendrola J.M., Lemmon M.A. ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface. FEBS Lett. 2004, 569:332-336.
36. Shi F., Telesco S.E., Liu Y., Radhakrishnan R., Lemmon M.A. ErbB3/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7692-7697.
37. Melenhorst W.B., Visser L., Timmer A., van den Heuvel M.C., Stegeman C.A., van Goor H. ADAM17 upregulation in human renal disease: a role in modulating TGF-{alpha} availability?. Am. J. Physiol. Ren. Physiol. 2009, 297:F781-F790.
38. Blobel C.P., Carpenter G., Freeman M. The role of protease activity in ErbB biology. Exp. Cell Res. 2009, 315:671-682.
39. Sanderson M.P., Dempsey P.J., Dunbar A.J. Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors. Growth Factors 2006, 24:121-136.
40. Ohtsu H., Dempsey P.J., Eguchi S. ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am. J. Physiol. Cell Physiol. 2006, 291:C1-C10.
41. Lautrette A., Li S., Alili R., Sunnarborg S.W., Burtin M., Lee D.C., Friedlander G., Terzi F. Angiotensin II and EGF receptor cross-talk in chronic kidney diseases: a new therapeutic approach. Nat. Med. 2005, 11:867-874.
42. Kramarenko I.I., Bunni M.A., Raymond J.R., Garnovskaya M.N. Bradykinin B2 Receptor interacts with integrin alpha5beta1 to transactivate epidermal growth factor receptor in kidney cells. Mol. Pharmacol. 2010.
43. Suzuki M., Raab G., Moses M.A., Fernandez C.A., Klagsbrun M. Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site. J. Biol. Chem. 1997, 272:31730-31737.
44. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 2003, 92:827-839.
45. Arnould C., Lelievre-Pegorier M., Ronco P., Lelongt B. MMP9 limits apoptosis and stimulates branching morphogenesis during kidney development. J. Am. Soc. Nephrol. 2009, 20:2171-2180.
46. Mitsudomi T., Yatabe Y. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 2010, 277:301-308.
47. Blume-Jensen P., Hunter T. Oncogenic kinase signalling. Nature 2001, 411:355-365.
48. Gesualdo L., Di P.S., Calabro A., Milani S., Maiorano E., Ranieri E., Pannarale G., Schena F.P. Expression of epidermal growth factor and its receptor in normal and diseased human kidney: an immunohistochemical and in situ hybridization study. Kidney Int. 1996, 49:656-665.
49. Wilson P.D. A plethora of epidermal growth factor-like proteins in polycystic kidneys. Kidney Int. 2004, 65:2441-2442.
50. Flores-Benitez D., Ruiz-Cabrera A., Flores-Maldonado C., Shoshani L., Cereijido M., Contreras R.G. Control of tight junctional sealing: role of epidermal growth factor. Am. J. Physiol. Ren. Physiol. 2007, 292:F828-F836.
51. Flores-Benitez D., Rincon-Heredia R., Razgado L.F., Larre I., Cereijido M., Contreras R.G. Control of tight junctional sealing: roles of epidermal growth factor and prostaglandin E2. Am. J. Physiol. Cell Physiol. 2009, 297:C611-C620.
52. Amasheh S., Milatz S., Krug S.M., Markov A.G., Gunzel D., Amasheh M., Fromm M. Tight junction proteins as channel formers and barrier builders. Ann. NY Acad. Sci. 2009, 1165:211-219.
53. Singh A.B., Sugimoto K., Dhawan P., Harris R.C. Juxtacrine activation of EGFR regulates claudin expression and increases transepithelial resistance. Am. J. Physiol. Cell Physiol. 2007, 293:C1660-C1668.
54. Smith J.P., Pozzi A., Dhawan P., Singh A.B., Harris R.C. Soluble HB-EGF induces epithelial-to-mesenchymal transition in inner medullary collecting duct cells by upregulating Snail-2. Am. J. Physiol. Ren. Physiol. 2009, 296:F957-F965.
55. Muthuswamy S.K., Gilman M., Brugge J.S. Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers. Mol. Cell. Biol. 1999, 19:6845-6857.
56. Katsuyama M., Masuyama T., Komura I., Hibino T., Takahashi H. Characterization of a novel polycystic kidney rat model with accompanying polycystic liver. Exp. Anim. 2000, 49:51-55.
57. Harris P.C. Homer W. Smith Award: insights into the pathogenesis of polycystic kidney disease from gene discovery. J. Am. Soc. Nephrol. 2009, 20:1188-1198.
58. Wilson P.D. Polycystic kidney disease: new understanding in the pathogenesis. Int. J. Biochem. Cell Biol. 2004, 36:1868-1873.
59. Torres V.E., Harris P.C. Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nat. Clin. Pract. Nephrol. 2006, 2:40-55.
60. Gabow P.A. Autosomal dominant polycystic kidney disease. N Engl J. Med. 1993, 329:332-342.
61. Hughes J., Ward C.J., Peral B., Aspinwall R., Clark K., San Millan J.L., Gamble V., Harris P.C. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 1995, 10:151-160.
62. Newby L.J., Streets A.J., Zhao Y., Harris P.C., Ward C.J., Ong A.C. Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex. J. Biol. Chem. 2002, 277:20763-20773.
63. Hanaoka K., Qian F., Boletta A., Bhunia A.K., Piontek K., Tsiokas L., Sukhatme V.P., Guggino W.B., Germino G.G. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000, 408:990-994.
64. Ibraghimov-Beskrovnaya O., Bukanov N.O., Donohue L.C., Dackowski W.R., Klinger K.W., Landes G.M. Strong homophilic interactions of the Ig-like domains of polycystin-1, the protein product of an autosomal dominant polycystic kidney disease gene, PKD1. Hum. Mol. Genet. 2000, 9:1641-1649.
65. Geng L., Burrow C.R., Li H.P., Wilson P.D. Modification of the composition of polycystin-1 multiprotein complexes by calcium and tyrosine phosphorylation. Biochim. Biophys. Acta 2000, 1535:21-35.
66. Ward C.J., Turley H., Ong A.C., Comley M., Biddolph S., Chetty R., Ratcliffe P.J., Gattner K., Harris P.C. Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:1524-1528.
67. Yamaguchi T., Hempson S.J., Reif G.A., Hedge A.M., Wallace D.P. Calcium Restores a Normal Proliferation Phenotype in Human Polycystic Kidney Disease Epithelial Cells. J. Am. Soc. Nephrol. 2006, 17:178-187.
68. Li X., Magenheimer B.S., Xia S., Johnson T., Wallace D.P., Calvet J.P., Li R. A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease. Nat. Med. 2008, 14:863-868.
69. Bhunia A.K., Piontek K., Boletta A., Liu L., Qian F., Xu P.N., Germino F.J., Germino G.G. PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell 2002, 109:157-168.
70. Tsiokas L., Kim E., Arnould T., Sukhatme V.P., Walz G. Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6965-6970.
71. Tsiokas L., Arnould T., Zhu C., Kim E., Walz G., Sukhatme V.P. Specific association of the gene product of PKD2 with the TRPC1 channel. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:3934-3939.
72. Nauli S.M., Alenghat F.J., Luo Y., Williams E., Vassilev P., Li X., Elia A.E., Lu W., Brown E.M., Quinn S.J., Ingber D.E., Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat. Genet. 2003, 33:129-137.
73. Qian F., Germino F.J., Cai Y., Zhang X., Somlo S., Germino G.G. PKD1 interacts with PKD2 through a probable coiled-coil domain. Nat. Genet. 1997, 16:179-183.
74. Babich V., Zeng W.Z., Yeh B.I., Ibraghimov-Beskrovnaya O., Cai Y., Somlo S., Huang C.L. The N-terminal extracellular domain is required for polycystin-1-dependent channel activity. J. Biol. Chem. 2004, 279:25582-25589.
75. Delmas P., Nauli S.M., Li X., Coste B., Osorio N., Crest M., Brown D.A., Zhou J. Gating of the polycystin ion channel signaling complex in neurons and kidney cells. FASEB J. 2004, 18:740-742.
76. Sharif-Naeini R., Folgering J.H., Bichet D., Duprat F., Lauritzen I., Arhatte M., Jodar M., Dedman A., Chatelain F.C., Schulte U., Retailleau K., Loufrani L., Patel A., Sachs F., Delmas P., Peters D.J., Honore E. Polycystin-1 and -2 dosage regulates pressure sensing. Cell 2009, 139:587-596.
77. Giamarchi A., Feng S., Rodat-Despoix L., Xu Y., Bubenshchikova E., Newby L.J., Hao J., Gaudioso C., Crest M., Lupas A.N., Honore E., Williamson M.P., Obara T., Ong A.C., Delmas P. A polycystin-2 (TRPP2) dimerization domain essential for the function of heteromeric polycystin complexes. EMBO J. 2010, 29:1176-1191.
78. Yu Y., Ulbrich M.H., Li M.H., Buraei Z., Chen X.Z., Ong A.C., Tong L., Isacoff E.Y., Yang J. Structural and molecular basis of the assembly of the TRPP2/PKD1 complex. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:11558-11563.
79. Woudenberg-Vrenken T.E., Bindels R.J., Hoenderop J.G. The role of transient receptor potential channels in kidney disease. Nat. Rev. Nephrol. 2009, 5:441-449.
80. Kiselyov K., Soyombo A., Muallem S. TRPpathies. J. Physiol. 2007, 578:641-653.
81. Zhou J. Polycystins and primary cilia: primers for cell cycle progression. Anu. Rev. Physiol. 2009, 71:83-113.
82. Tsiokas L. Function and regulation of TRPP2 at the plasma membrane. Am. J. Physiol. Ren. Physiol. 2009, 297:F1-F9.
83. Mochizuki T., Wu G., Hayashi T., Xenophontos S.L., Veldhuisen B., Saris J.J., Reynolds D.M., Cai Y., Gabow P.A., Pierides A., Kimberling W.J., Breuning M.H., Deltas C.C., Peters D.J., Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996, 272:1339-1342.
84. Kottgen M., Buchholz B., Garcia-Gonzalez M.A., Kotsis F., Fu X., Doerken M., Boehlke C., Steffl D., Tauber R., Wegierski T., Nitschke R., Suzuki M., Kramer-Zucker A., Germino G.G., Watnick T., Prenen J., Nilius B., Kuehn E.W., Walz G. TRPP2 and TRPV4 form a polymodal sensory channel complex. J. Cell Biol. 2008, 182:437-447.
85. Bai C.X., Giamarchi A., Rodat-Despoix L., Padilla F., Downs T., Tsiokas L., Delmas P. Formation of a new receptor-operated channel by heteromeric assembly of TRPP2 and TRPC1 subunits. EMBO Rep. 2008, 9:472-479.
86. Kobori T., Smith G.D., Sandford R., Edwardson J.M. The transient receptor potential channels TRPP2 and TRPC1 form a heterotetramer with a 2:2 stoichiometry and an alternating subunit arrangement. J. Biol. Chem. 2009, 284:35507-35513.
87. Staruschenko A., Jeske N.A., Akopian A.N. Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel. J. Biol. Chem. 2010, 285:15167-15177.
88. Onuchic L.F., Furu L., Nagasawa Y., Hou X., Eggermann T., Ren Z., Bergmann C., Senderek J., Esquivel E., Zeltner R., Rudnik-Schoneborn S., Mrug M., Sweeney W., Avner E.D., Zerres K., Guay-Woodford L.M., Somlo S., Germino G.G. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am. J. Hum. Genet. 2002, 70:1305-1317.
89. Ward C.J., Hogan M.C., Rossetti S., Walker D., Sneddon T., Wang X., Kubly V., Cunningham J.M., Bacallao R., Ishibashi M., Milliner D.S., Torres V.E., Harris P.C. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat. Genet. 2002, 30:259-269.
90. Nagasawa Y., Matthiesen S., Onuchic L.F., Hou X., Bergmann C., Esquivel E., Senderek J., Ren Z., Zeltner R., Furu L., Avner E., Moser M., Somlo S., Guay-Woodford L., Buttner R., Zerres K., Germino G.G. Identification and characterization of Pkhd1, the mouse orthologue of the human ARPKD gene. J. Am. Soc. Nephrol. 2002, 13:2246-2258.
91. Hogan M.C., Griffin M.D., Rossetti S., Torres V.E., Ward C.J., Harris P.C. PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression. Hum. Mol. Genet. 2003, 12:685-698.
92. Menezes L.F., Cai Y., Nagasawa Y., Silva A.M., Watkins M.L., Da Silva A.M., Somlo S., Guay-Woodford L.M., Germino G.G., Onuchic L.F. Polyductin, the PKHD1 gene product, comprises isoforms expressed in plasma membrane, primary cilium, and cytoplasm. Kidney Int. 2004, 66:1345-1355.
93. Wang S., Luo Y., Wilson P.D., Witman G.B., Zhou J. The autosomal recessive polycystic kidney disease protein is localized to primary cilia, with concentration in the basal body area. J. Am. Soc. Nephrol. 2004, 15:592-602.
94. Ward C.J., Yuan D., Masyuk T.V., Wang X., Punyashthiti R., Whelan S., Bacallao R., Torra R., LaRusso N.F., Torres V.E., Harris P.C. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Hum. Mol. Genet. 2003, 12:2703-2710.
95. Zhang M.Z., Mai W., Li C., Cho S.Y., Hao C., Moeckel G., Zhao R., Kim I., Wang J., Xiong H., Wang H., Sato Y., Wu Y., Nakanuma Y., Lilova M., Pei Y., Harris R.C., Li S., Coffey R.J., Sun L., Wu D., Chen X.Z., Breyer M.D., Zhao Z.J., McKanna J.A., Wu G. PKHD1 protein encoded by the gene for autosomal recessive polycystic kidney disease associates with basal bodies and primary cilia in renal epithelial cells. Proc. Natl Acad. Sci. USA 2004, 101:2311-2316.
96. Kim I., Fu Y., Hui K., Moeckel G., Mai W., Li C., Liang D., Zhao P., Ma J., Chen X.Z., George A.L., Coffey R.J., Feng Z.P., Wu G. Fibrocystin/polyductin modulates renal tubular formation by regulating polycystin-2 expression and function. J. Am. Soc. Nephrol. 2008, 19:455-468.
97. Wang S., Zhang J., Nauli S.M., Li X., Starremans P.G., Luo Y., Roberts K.A., Zhou J. Fibrocystin/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia. Mol. Cell. Biol. 2007, 27:3241-3252.
98. Israeli S., Amsler K., Zheleznova N., Wilson P.D. Abnormalities in focal adhesion complex formation, regulation, and function in human autosomal recessive polycystic kidney disease epithelial cells. Am. J. Physiol. Cell Physiol. 2010, 298:C831-C846.
99. Sweeney W.E., Chen Y., Nakanishi K., Frost P., Avner E.D. Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int. 2000, 57:33-40.
100. Sweeney W.E., Avner E.D. Functional activity of epidermal growth factor receptors in autosomal recessive polycystic kidney disease. Am. J. Physiol. 1998, 275:F387-F394.
101. Sweeney W.E., Avner E.D. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res. 2006, 326:671-685.
102. Nakanishi K., Sweeney W., Avner E.D. Segment-specific c-ErbB2 expression in human autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 2001, 12:379-384.
103. Torres V.E., Sweeney W.E., Wang X., Qian Q., Harris P.C., Frost P., Avner E.D. Epidermal growth factor receptor tyrosine kinase inhibition is not protective in PCK rats. Kidney Int. 2004, 66:1766-1773.
104. Sweeney W.E., von Vigier R.O., Frost P., Avner E.D. Src inhibition ameliorates polycystic kidney disease. J. Am. Soc. Nephrol. 2008, 19:1331-1341.
105. Citri A., Yarden Y. EGF-ERBB signalling: towards the systems level. Nat. Rev. Mol. Cell Biol. 2006, 7:505-516.
106. Schlessinger J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 2004, 306:1506-1507.
107. Waterman H., Yarden Y. Molecular mechanisms underlying endocytosis and sorting of ErbB receptor tyrosine kinases. FEBS Lett. 2001, 490:142-152.
108. Wilson P.D., Du J., Norman J.T. Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease. Eur. J. Cell Biol. 1993, 61:131-138.
109. MacRae D.K., Nemo R., Sweeney W.E., Avner E.D. EGF-related growth factors in the pathogenesis of murine ARPKD. Kidney Int. 2004, 65:2018-2029.
110. Lowden D.A., Lindemann G.W., Merlino G., Barash B.D., Calvet J.P., Gattone V.H. Renal cysts in transgenic mice expressing transforming growth factor-alpha. J. Lab. Clin. Med. 1994, 124:386-394.
111. Richards W.G., Sweeney W.E., Yoder B.K., Wilkinson J.E., Woychik R.P., Avner E.D. Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease. J. Clin. Invest. 1998, 101:935-939.
112. Biscardi J.S., Maa M.C., Tice D.A., Cox M.E., Leu T.H., Parsons S.J. c-Src-mediated phosphorylation of the epidermal growth factor receptor on Tyr845 and Tyr1101 is associated with modulation of receptor function. J. Biol. Chem. 1999, 274:8335-8343.
113. Cooper J.A., Howell B. The when and how of Src regulation. Cell 1993, 73:1051-1054.
114. Orellana S.A., Sweeney W.E., Neff C.D., Avner E.D. Epidermal growth factor receptor expression is abnormal in murine polycystic kidney. Kidney Int. 1995, 47:490-499.
115. Goilav B., Satlin L.M., Wilson P.D. Pathways of apoptosis in human autosomal recessive and autosomal dominant polycystic kidney diseases. Pediatr. Nephrol. 2008, 23:1473-1482.
116. Ryan S., Verghese S., Cianciola N.L., Cotton C.U., Carlin C.R. Autosomal recessive polycystic kidney disease epithelial cell model reveals multiple basolateral epidermal growth factor receptor sorting pathways. Mol. Biol. Cell 2010, 21:2732-2745.
117. Wang Z., Zhang L., Yeung T.K., Chen X. Endocytosis deficiency of epidermal growth factor (EGF) receptor-ErbB2 heterodimers in response to EGF stimulation. Mol. Biol. Cell 1999, 10:1621-1636.
118. Hazan R., Margolis B., Dombalagian M., Ullrich A., Zilberstein A., Schlessinger J. Identification of autophosphorylation sites of HER2/neu. Cell Growth Differ. 1990, 1:3-7.
119. Nauta J., Sweeney W.E., Rutledge J.C., Avner E.D. Biliary epithelial cells from mice with congenital polycystic kidney disease are hyperresponsive to epidermal growth factor. Pediatr. Res. 1995, 37:755-763.
120. Spencer K.S., Graus-Porta D., Leng J., Hynes N.E., Klemke R.L. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J. Cell Biol. 2000, 148:385-397.
121. Graus-Porta D., Beerli R.R., Hynes N.E. Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol. 1995, 15:1182-1191.
122. Beerli R.R., Graus-Porta D., Woods-Cook K., Chen X., Yarden Y., Hynes N.E. Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol. 1995, 15:6496-6505.
123. Wilson S.J., Amsler K., Hyink D.P., Li X., Lu W., Zhou J., Burrow C.R., Wilson P.D. Inhibition of HER-2(neu/ErbB2) restores normal function and structure to polycystic kidney disease (PKD) epithelia. Biochim. Biophys. Acta 2006, 1762:647-655.
124. M.B.Butterworth Regulation of the epithelial sodium channel (ENaC) by membrane trafficking. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease 2010, 1802:1166-1177.
125. Garty H., Palmer L.G. Epithelial sodium channels: function, structure, and regulation. Physiol. Rev. 1997, 77:359-396.
126. Alvarez de la Rosa D., Canessa C.M., Fyfe G.K., Zhang P. Structure and regulation of amiloride-sensitive sodium channels. Annu. Rev. Physiol. 2000, 62:573-594.
127. Kellenberger S., Schild L. Epithelial sodium channel/degenerin family of ion channels: a variety of functions for a shared structure. Physiol. Rev. 2002, 82:735-767.
128. Schild L. The epithelial sodium channel: from molecule to disease. Rev. Physiol. Biochem. Pharmacol. 2004, 151:93-107.
129. Bhalla V., Hallows K.R. Mechanisms of ENaC regulation and clinical implications. J. Am. Soc. Nephrol. 2008, 19:1845-1854.
130. Eaton D.C., Helms M.N., Koval M., Bao H.F., Jain L. The Contribution of Epithelial Sodium Channels to Alveolar Function in Health and Disease. An. Rev. Physiol. 2009, 71:403-423.
131. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
132. E.D. Avner, W.E. Sweeney, Jr., Renal cystic disease: new insights for the clinician, Pediatr. Clin. North Am. 53 (2006) 889-909, ix.
133. Wilson P.D. Epithelial cell polarity and disease. Am. J. Physiol. 1997, 272:F434-F442.
134. Guay-Woodford L.M. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am. J. Physiol. Ren. Physiol. 2003, 285:F1034-F1049.
135. Ma R., Sansom S.C. Epidermal growth factor activates store-operated calcium channels in human glomerular mesangial cells. J. Am. Soc. Nephrol. 2001, 12:47-53.
136. Li W.P., Tsiokas L., Sansom S.C., Ma R. Epidermal growth factor activates store-operated Ca2+ channels through an inositol 1, 4, 5-trisphosphate-independent pathway in human glomerular mesangial cells. J. Biol. Chem. 2004, 279:4570-4577.
137. Kiselyov K., Patterson R.L. The integrative function of TRPC channels. Front. Biosci. 2009, 14:45-58.
138. Dietrich A., Chubanov V., Gudermann T. Renal TRPathies. J. Am. Soc. Nephrol. 2010, 21:736-744.
139. Goel M., Sinkins W.G., Zuo C.D., Estacion M., Schilling W.P. Identification and localization of TRPC channels in the rat kidney. Am. J. Physiol. Ren. Physiol. 2006, 290:F1241-F1252.
140. Bezzerides V.J., Ramsey I.S., Kotecha S., Greka A., Clapham D.E. Rapid vesicular translocation and insertion of TRP channels. Nat. Cell Biol. 2004, 6:709-720.
141. Karpushev A., Pavlov T., Staruschenko A. Regulation of the epithelial sodium channels (ENaC) by small G proteins and phosphatidylinositides. Biochemistry (Moscow) Supplemental Series A: Membrane and Cell Biology 2009, 3:261-274.
142. Pochynyuk O., Medina J., Gamper N., Genth H., Stockand J.D., Staruschenko A. Rapid translocation and insertion of the epithelial Na+channel in response to RhoA signaling. J. Biol. Chem. 2006, 281:26520-26527.
143. Pochynyuk O., Staruschenko A., Bugaj V., Lagrange L., Stockand J.D. Quantifying RhoA facilitated trafficking of the epithelial Na+channel toward the plasma membrane with total internal reflection fluorescence-fluorescence recovery after photobleaching. J. Biol. Chem. 2007, 282:14576-14585.
144. Staruschenko A., Nichols A., Medina J.L., Camacho P., Zheleznova N.N., Stockand J.D. Rho small GTPases activate the epithelial Na(+) channel. J. Biol. Chem. 2004, 279:49989-49994.
145. Walder R.Y., Landau D., Meyer P., Shalev H., Tsolia M., Borochowitz Z., Boettger M.B., Beck G.E., Englehardt R.K., Carmi R., Sheffield V.C. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet. 2002, 31:171-174.
146. Schlingmann K.P., Weber S., Peters M., Niemann N.L., Vitzthum H., Klingel K., Kratz M., Haddad E., Ristoff E., Dinour D., Syrrou M., Nielsen S., Sassen M., Waldegger S., Seyberth H.W., Konrad M. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet. 2002, 31:166-170.
147. Groenestege W.M., Thebault S., van der W.J., Janssen R., Tejpar S., van den Heuvel L.P., van C.E., Hoenderop J.G., Knoers N.V., Bindels R.J., van den B.D. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J. Clin. Invest. 2007, 117:2260-2267.
148. Ikari A., Okude C., Sawada H., Yamazaki Y., Sugatani J., Miwa M. TRPM6 expression and cell proliferation are up-regulated by phosphorylation of ERK1/2 in renal epithelial cells. Biochem. Biophys. Res. Commun. 2008, 369:1129-1133.
149. Ikari A., Sanada A., Okude C., Sawada H., Yamazaki Y., Sugatani J., Miwa M. Up-regulation of TRPM6 transcriptional activity by AP-1 in renal epithelial cells. J. Cell. Physiol. 2010, 222:481-487.
150. Thebault S., Alexander R.T., Tiel Groenestege W.M., Hoenderop J.G., Bindels R.J. EGF increases TRPM6 activity and surface expression. J. Am. Soc. Nephrol. 2009, 20:78-85.
151. Dimke H. W.J. van der, T.R. Alexander, I.M. Meijer, G.M. Mulder, G.H. van, S. Tejpar, J.G. Hoenderop, R.J. Bindels, Effects of the EGFR inhibitor erlotinib on magnesium handling. J. Am. Soc. Nephrol. 2010, 21:1309-1316.
152. Ma R., Li W.P., Rundle D., Kong J., Akbarali H.I., Tsiokas L. PKD2 functions as an epidermal growth factor-activated plasma membrane channel. Mol. Cell. Biol. 2005, 25:8285-8298.
153. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., LaMantia C., Mourton T., Herrup K., Harris R.C. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 1995, 269:230-234.
154. Rundle D.R., Gorbsky G., Tsiokas L. PKD2 interacts and co-localizes with mDia1 to mitotic spindles of dividing cells: role of mDia1 IN PKD2 localization to mitotic spindles. J. Biol. Chem. 2004, 279:29728-29739.
155. Bai C.X., Kim S., Li W.P., Streets A.J., Ong A.C., Tsiokas L. Activation of TRPP2 through mDia1-dependent voltage gating. EMBO J. 2008, 27:1345-1356.
156. Danto S.I., Borok Z., Zhang X.L., Lopez M.Z., Patel P., Crandall E.D., Lubman R.L. Mechanisms of EGF-induced stimulation of sodium reabsorption by alveolar epithelial cells. Am. J. Physiol. 1998, 275:C82-C92.
157. Khurana S., Nath S.K., Levine S.A., Bowser J.M., Tse C.M., Cohen M.E., Donowitz M. Brush border phosphatidylinositol 3-kinase mediates epidermal growth factor stimulation of intestinal NaCl absorption and Na+/H+exchange. J. Biol. Chem. 1996, 271:9919-9927.
158. Muto S., Furuya H., Tabei K., Asano Y. Site and mechanism of action of epidermal growth factor in rabbit cortical collecting duct. Am. J. Physiol. 1991, 260:F163-F169.
159. Vehaskari V.M., Hering-Smith K.S., Moskowitz D.W., Weiner I.D., Hamm L.L. Effect of epidermal growth factor on sodium transport in the cortical collecting tubule. Am. J. Physiol. 1989, 256:F803-F809.
160. Vehaskari V.M., Herndon J., Hamm L.L. Mechanism of sodium transport inhibition by epidermal growth factor in cortical collecting ducts. Am. J. Physiol. 1991, 261:F896-F903.
161. Warden D.H., Stokes J.B. EGF and PGE2 inhibit rabbit CCD Na+transport by different mechanisms: PGE2 inhibits Na(+)-K+pump. Am. J. Physiol. 1993, 264:F670-F677.
162. Falin R., Veizis I.E., Cotton C.U. A role for ERK1/2 in EGF- and ATP-dependent regulation of amiloride-sensitive sodium absorption. Am. J. Physiol. Cell Physiol. 2005, 288:C1003-C1011.
163. Shen J.P., Cotton C.U. Epidermal growth factor inhibits amiloride-sensitive sodium absorption in renal collecting duct cells. Am. J. Physiol. Ren. Physiol. 2003, 284:F57-F64.
164. Cao L., Owsianik G., Becq F., Nilius B. Chronic exposure to EGF affects trafficking and function of ENaC channel in cystic fibrosis cells. Biochem. Biophys. Res. Commun. 2005, 331:503-511.
165. Tong Q., Stockand J.D. Receptor tyrosine kinases mediate epithelial Na(+) channel inhibition by epidermal growth factor. Am. J. Physiol. Ren. Physiol. 2005, 288:F150-F161.
166. Falin R.A., Cotton C.U. Acute downregulation of ENaC by EGF involves the PY motif and putative ERK phosphorylation site. J. Gen. Physiol. 2007, 130:313-328.
167. Grossmann C., Freudinger R., Mildenberger S., Krug A.W., Gekle M. Evidence for epidermal growth factor receptor as negative-feedback control in aldosterone-induced Na+reabsorption. Am. J. Physiol. Ren. Physiol. 2004, 286:F1226-F1231.
168. Markadieu N., Crutzen R., Blero D., Erneux C., Beauwens R. Hydrogen peroxide and epidermal growth factor activate phosphatidylinositol 3-kinase and increase sodium transport in A6 cell monolayers. Am. J. Physiol. Ren. Physiol. 2005, 288:F1201-F1212.
169. Liu L., Duke B.J., Malik B., Yue Q., Eaton D.C. Biphasic regulation of ENaC by TGF-{alpha} and EGF in renal epithelial cells. Am. J. Physiol. Ren. Physiol. 2009, 296:F1417-F1427.
170. Takemura Y., Goodson P., Bao H.F., Jain L., Helms M.N. Rac1-mediated NADPH oxidase release of OFormula regulates epithelial sodium channel activity in the alveolar epithelium. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 298:L509-L520.
171. Michlig S., Mercier A., Doucet A., Schild L., Horisberger J.D., Rossier B.C., Firsov D. ERK1/2 controls Na, K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney. J. Biol. Chem. 2004, 279:51002-51012.
172. Booth R.E., Stockand J.D. Targeted degradation of ENaC in response to PKC activation of the ERK1/2 cascade. Am. J. Physiol. Ren. Physiol. 2003, 284:F938-F947.
173. Staruschenko A., Patel P., Tong Q., Medina J.L., Stockand J.D. Ras activates the epithelial Na(+) channel through phosphoinositide 3-OH kinase signaling. J. Biol. Chem. 2004, 279:37771-37778.
174. Staruschenko A., Pochynyuk O.M., Tong Q., Stockand J.D. Ras couples phosphoinositide 3-OH kinase to the epithelial Na+channel. Biochim. Biophys. Acta 2005, 1669:108-115.
175. Staruschenko A., Pochynyuk O., Vandewalle A., Bugaj V., Stockand J.D. Acute regulation of the epithelial Na+channel by phosphatidylinositide 3-OH kinase signaling in native collecting duct principal cells. J. Am. Soc. Nephrol. 2007, 18:1652-1661.
176. Mastroberardino L., Spindler B., Forster I., Loffing J., Assandri R., May A., Verrey F. ras pathway activates epithelial Na+channel and decreases its surface expression in Xenopus oocytes. Mol. Biol. Cell 1998, 9:3417-3427.
177. Spindler B., Mastroberardino L., Custer M., Verrey F. Characterization of early aldosterone-induced RNAs identified in A6 kidney epithelia. Pflugers Arch. 1997, 434:323-331.
178. Spindler B., Verrey F. Aldosterone action: induction of p21ras and fra-2 and transcription-independent decrease in myc, jun, and fos. Am. J. Physiol. Cell Physiol. 1999, 276:C1154-C1161.
179. Stockand J.D., Spier B.J., Worrell R.T., Yue G., Al-Baldawi N., Eaton D.C. Regulation of Na+reabsorption by the aldosterone-induced small G protein K-Ras2A. J. Biol. Chem. 1999, 274:35449-35454.
180. Woodall A.J., Richards M.A., Turner D.J., Fitzgerald E.M. Growth factors differentially regulate neuronal Cav channels via ERK-dependent signalling. Cell Calcium 2008, 43:562-575.
181. Franch H.A., Wang X., Sooparb S., Brown N.S., Du J. Phosphatidylinositol 3-kinase activity is required for epidermal growth factor to suppress proteolysis. J. Am. Soc. Nephrol. 2002, 13:903-909.
182. Mazak I., Fiebeler A., Muller D.N., Park J.K., Shagdarsuren E., Lindschau C., Dechend R., Viedt C., Pilz B., Haller H., Luft F.C. aldosterone potentiates angiotensin II-induced signaling in vascular smooth muscle cells. Circulation 2004, 109:2792-2800.
183. Huang S., Zhang A., Ding G., Chen R. Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am. J. Physiol. Ren. Physiol. 2009, 296:F1323-F1333.
184. Shibata S., Nagase M., Yoshida S., Kawarazaki W., Kurihara H., Tanaka H., Miyoshi J., Takai Y., Fujita T. Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat. Med. 2008, 14:1370-1376.
185. Fujita T. Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010, 55:813-818.
186. Silva G.B., Garvin J.L. Rac1 mediates NaCl-induced superoxide generation in the thick ascending limb. Am. J. Physiol. Ren. Physiol. 2009, 298:F421-F425.
187. Ma H.P., Chou C.F., Wei S.P., Eaton D.C. Regulation of the epithelial sodium channel by phosphatidylinositides: experiments, implications, and speculations. Pflugers Arch. 2007, 455:169-180.
188. Berdiev B.K., Shlyonsky V.G., Karlson K.H., Stanton B.A., Ismailov I.I. Gating of amiloride-sensitive Na(+) channels: subunit-subunit interactions and inhibition by the cystic fibrosis transmembrane conductance regulator. Biophys. J. 2000, 78:1881-1894.
189. Burch L.H., Talbot C.R., Knowles M.R., Canessa C.M., Rossier B.C., Boucher R.C. Relative expression of the human epithelial Na+channel subunits in normal and cystic fibrosis airways. Am. J. Physiol. 1995, 269:C511-C518.
190. Stutts M.J., Canessa C.M., Olsen J.C., Hamrick M., Cohn J.A., Rossier B.C., Boucher R.C. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995, 269:847-850.
191. Stutts M.J., Rossier B.C., Boucher R.C. Cystic fibrosis transmembrane conductance regulator inverts protein kinase A-mediated regulation of epithelial sodium channel single channel kinetics. J. Biol. Chem. 1997, 272:14037-14040.
192. Berdiev B.K., Qadri Y.J., Benos D.J. Assessment of the CFTR and ENaC association. Mol. Biosyst. 2009, 5:123-127.
193. Mall M., Grubb B.R., Harkema J.R., O'Neal W.K., Boucher R.C. Increased airway epithelial Na+absorption produces cystic fibrosis-like lung disease in mice. Nat. Med. 2004, 10:487-493.
194. Myerburg M.M., Butterworth M.B., McKenna E.E., Peters K.W., Frizzell R.A., Kleyman T.R., Pilewski J.M. Airway surface liquid volume regulates ENaC by altering the serine protease-protease inhibitor balance: a mechanism for sodium hyperabsorption in cystic fibrosis. J. Biol. Chem. 2006, 281:27942-27949.
195. Hanaoka K., Devuyst O., Schwiebert E.M., Wilson P.D., Guggino W.B. A role for CFTR in human autosomal dominant polycystic kidney disease. Am. J. Physiol. 1996, 270:C389-C399.
196. Magenheimer B.S., St John P.L., Isom K.S., Abrahamson D.R., De Lisle R.C., Wallace D.P., Maser R.L., Grantham J.J., Calvet J.P. Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+), K(+), 2Cl(-) Co-transporter-dependent cystic dilation. J. Am. Soc. Nephrol. 2006, 17:3424-3437.
197. Yang B., Sonawane N.D., Zhao D., Somlo S., Verkman A.S. Small-molecule CFTR inhibitors slow cyst growth in polycystic kidney disease. J. Am. Soc. Nephrol. 2008, 19:1300-1310.
198. Nakanishi K., Sweeney W.E., MacRae D.K., Cotton C.U., Avner E.D. Role of CFTR in autosomal recessive polycystic kidney disease. J. Am. Soc. Nephrol. 2001, 12:719-725.
199. Bens M., Chassin C., Vandewalle A. Regulation of NaCl transport in the renal collecting duct: lessons from cultured cells. Pflugers Arch. 2006, 453:133-146.
200. Hamm L.L., Feng Z., Hering-Smith K.S. Regulation of sodium transport by ENaC in the kidney. Curr. Opin. Nephrol. Hypertens. 2010, 19:98-105.
201. Gray M.A. Primary cilia and regulation of renal Na+transport. Focus on "Heightened epithelial Na+channel-mediated Na+absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia". Am. J. Physiol. Cell Physiol. 2006, 290:C947-C949.
202. Olteanu D., Yoder B.K., Liu W., Croyle M.J., Welty E.A., Rosborough K., Wyss J.M., Bell P.D., Guay-Woodford L.M., Bevensee M.O., Satlin L.M., Schwiebert E.M. Heightened epithelial Na+channel-mediated Na+absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia. Am. J. Physiol. Cell Physiol. 2006, 290:C952-C963.
203. Veizis E.I., Carlin C.R., Cotton C.U. Decreased amiloride-sensitive Na+absorption in collecting duct principal cells isolated from BPK ARPKD mice. Am. J. Physiol. Ren. Physiol. 2004, 286:F244-F254.
204. Veizis I.E., Cotton C.U. Abnormal EGF-dependent regulation of sodium absorption in ARPKD collecting duct cells. Am. J. Physiol. Ren. Physiol. 2005, 288:F474-F482.
205. Rohatgi R., Greenberg A., Burrow C.R., Wilson P.D., Satlin L.M. Na transport in autosomal recessive polycystic kidney disease (ARPKD) cyst lining epithelial cells. J. Am. Soc. Nephrol. 2003, 14:827-836.
206. Calvet J.P., Grantham J.J. The genetics and physiology of polycystic kidney disease. Semin. Nephrol. 2001, 21:107-123.
207. Ye M., Grant M., Sharma M., Elzinga L., Swan S., Torres V.E., Grantham J.J. Cyst fluid from human autosomal dominant polycystic kidneys promotes cyst formation and expansion by renal epithelial cells in vitro. J. Am. Soc. Nephrol. 1992, 3:984-994.
208. Rohatgi R., Zavilowitz B., Vergara M., Woda C., Kim P., Satlin L.M. Cyst fluid composition in human autosomal recessive polycystic kidney disease. Pediatr. Nephrol. 2005, 20:552-553.
209. Hogan M.C., Masyuk T.V., Page L.J., Kubly V.J., Bergstralh E.J., Li X., Kim B., King B.F., Glockner J., Holmes D.R., Rossetti S., Harris P.C., LaRusso N.F., Torres V.E. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. J. Am. Soc. Nephrol. 2010, 21:1052-1061.